Utilizing its innovative ADC payload platform, Akari is advancing a new class of immuno-oncology ADCs built on the platform ...

Two human leukocyte antigen (HLA) class I alleles are independently associated with an increased risk for allopurinol-induced ...

Akari Therapeutics (AKTX) announced its abstract highlighting immune mechanism-of-action data for its novel ADC payload, PH1. The abstract is now ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing ...

This budget is about endurance, not relief. It invests heavily in the future while leaving most households to navigate the ...

CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage ...

Implementing seasonal math strategies in the fall is a simple yet powerful way to build early mathematical understanding.

Here's the thing about math that nobody tells you: it's less about memorizing formulas and more about knowing which tools to ...

Venetoclax-resistant secondary AML transformed from CMML responds to lenzilumab BURLINGAME, CA / ACCESS Newswire / November 4, 2025 / Taran Therapeutics ("Taran") a privately ...

Hohenstein Medical ? a division of Hohenstein Laboratories and a leading provider of testing, research and certification services for medical devices ? has hired Katie Brinkman as its biocompatibility ...

The corporate regulator’s chairman, Joe Longo, says public markets need a radical makeover to compete with the fast growth of private investments and credit.

James A. Robinson, co-winner of the Economics Nobel 2024, feels that artificial intelligence will lead to huge productivity ...